The clinical outcome of pazopanib treatment in Japanese patients with relapsed soft tissue sarcoma: A Japanese Musculoskeletal Oncology Group (JMOG) study

The clinical outcome of pazopanib treatment in Japanese patients with relapsed soft tissue sarcoma: A Japanese Musculoskeletal Oncology Group (JMOG) study

Clinical outcomes of 156 Japanese patients with relapsed soft tissue sarcoma receive pazopanib treatment are investigated. There are apparent differences in the efficacy of pazopanib treatment among histologic types of soft tissue sarcoma.

Bibliographic Details
Main Authors: Nakamura, Tomoki, Matsumine, Akihiko, Kawai, Akira, Araki, Nobuhito, Goto, Takahiro, Yonemoto, Tsukasa, Sugiura, Hideshi, Nishida, Yoshihiro, Hiraga, Hiroaki, Honoki, Kanya, Yasuda, Taketoshi, Boku, Shogen, Sudo, Akihiro, Ueda, Takafumi
Format: Online
Language:English
Published: John Wiley and Sons Inc. 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069581/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069581/

Similar Items